Harold J. Leraas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Harold J. Leraas has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Elisabeth T. Tracy
Division of Pediatric Surgery, UNC Children’s Hospital, University of North Carolina at Chapel Hill, Chapel Hill, USA
7 shared publications Brian F. Gilmore
Department of Surgery, Duke University Medical Center, Durham, North Carolina
6 shared publications- Brian Ezekian
Department of Surgery, Duke University Medical Center, Durham, NC, USA
5 shared publications John Migaly
Department of Surgery, Duke University Medical Center, Durham, North Carolina
5 shared publications- Brian R. Englum
Department of Surgery, University of Maryland , Baltimore, MD
4 shared publications Elisabeth T. Tracy
4 shared publications
Latest Publications
- Open Access
- 19 August 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (8) , e0002530
Towards attainment of the 2030 goal for childhood cancer survival for the World Health Organization Global Initiative for Childhood Cancer: An ecological, cross-sectional study
The World Health Organization (WHO) recently launched the Global Initiative for Childhood Cancer (GICC), with the goal of attaining at least 60% cancer survival for children worldwide by the year 2030. This study aims to describe the global patterns of childhood cancer survival in 2019 to help guide progress in attaining the GICC target goal. In this ecological, cross-sectional study, we used 5-year net childhood cancer survival (2015–2019) data from a prior micro-modeling study from 197 countries and territories. Descriptive statistics were used to analyze the patterns of overall childhood cancer survival and survival for each of the six cancer tracer diagnoses as proposed by the GICC. We used hot spot analysis to identify geographic clusters of high and low cancer survival. Most high-income countries reached at least 60% (92%, n = 59/64), net childhood cancer survival at baseline. No lower-middle-income or low-income country reached at least 60% overall cancer survival at baseline. The South-East Asia region had the highest proportion of countries that did not achieve at least 60% survival at baseline (100%, n = 10/10), followed by the African region (98%, n = 49/50). For each cancer tracer diagnosis, we found the highest number of countries that have achieved at least 60% survival was for Burkitt lymphoma (44%, n = 87/197) followed by acute lymphocytic leukemia (41%, n = 80/197).Hot spot analysis showed the highest overall survival was concentrated in North America and Europe, while the lowest survival was concentrated in Sub-Saharan Africa and South-East Asia.A majority of LMICs had not reached the WHO target goal of at least 60% survival from childhood cancer at baseline in 2019, with variable success for the six childhood cancer tracer diagnoses of the GICC. These findings provide baseline assessment of individual country performance to help achieve the GICC goal of 60% overall cancer survival globally by 2030.
- 19 August 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (8) , e0002530
Open AccessTowards attainment of the 2030 goal for childhood cancer survival for the World Health Organization Global Initiative for Childhood Cancer: An ecological, cross-sectional study
The World Health Organization (WHO) recently launched the Global Initiative for Childhood Cancer (GICC), with the goal of attaining at least 60% cancer survival for children worldwide by the year 2030. This study aims to describe the global patterns of childhood cancer survival in 2019 to help guide progress in attaining the GICC target goal. In this ecological, cross-sectional study, we used 5-year net childhood cancer survival (2015–2019) data from a prior micro-modeling study from 197 countries and territories. Descriptive statistics were used to analyze the patterns of overall childhood cancer survival and survival for each of the six cancer tracer diagnoses as proposed by the GICC. We used hot spot analysis to identify geographic clusters of high and low cancer survival. Most high-income countries reached at least 60% (92%, n = 59/64), net childhood cancer survival at baseline. No lower-middle-income or low-income country reached at least 60% overall cancer survival at baseline. The South-East Asia region had the highest proportion of countries that did not achieve at least 60% survival at baseline (100%, n = 10/10), followed by the African region (98%, n = 49/50). For each cancer tracer diagnosis, we found the highest number of countries that have achieved at least 60% survival was for Burkitt lymphoma (44%, n = 87/197) followed by acute lymphocytic leukemia (41%, n = 80/197).Hot spot analysis showed the highest overall survival was concentrated in North America and Europe, while the lowest survival was concentrated in Sub-Saharan Africa and South-East Asia.A majority of LMICs had not reached the WHO target goal of at least 60% survival from childhood cancer at baseline in 2019, with variable success for the six childhood cancer tracer diagnoses of the GICC. These findings provide baseline assessment of individual country performance to help achieve the GICC goal of 60% overall cancer survival globally by 2030.
- 25 January 2024
- Published by Elsevier in Journal of Surgical Education
- Vol. 81 (3) , 367-372
Longitudinal Integrated Clerkships and Undergraduate Surgical Education: A Scoping Review and Gap Analysis
- 25 January 2024
- Published by Elsevier in Journal of Surgical Education
- Vol. 81 (3) , 367-372
Longitudinal Integrated Clerkships and Undergraduate Surgical Education: A Scoping Review and Gap Analysis
- 28 December 2023
- Published by Elsevier in Journal of Surgical Education
- Vol. 81 (3) , 335-338
Who Benefits? An Assessment of Resident Benefits at Top 50 Academic Institutions
- 28 December 2023
- Published by Elsevier in Journal of Surgical Education
- Vol. 81 (3) , 335-338
Who Benefits? An Assessment of Resident Benefits at Top 50 Academic Institutions
- 22 September 2023
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 59 (1) , 129-133
Where Are the Children? A Thematic Analysis of State, Territory, and Tribal Organization Comprehensive Cancer Control Plans
- 22 September 2023
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 59 (1) , 129-133
Where Are the Children? A Thematic Analysis of State, Territory, and Tribal Organization Comprehensive Cancer Control Plans
- 20 September 2023
- Published by Elsevier in Journal of Surgical Research
- Vol. 293, 121-127
The Use of Parenteral Nutrition and Disparities in Its Allocation Following Traumatic Injury
- 20 September 2023
- Published by Elsevier in Journal of Surgical Research
- Vol. 293, 121-127
The Use of Parenteral Nutrition and Disparities in Its Allocation Following Traumatic Injury
- 4 August 2023
- Published by Elsevier in Journal of Surgical Research
- Vol. 291, 640-645
Using Crowdfunding Campaigns to Examine Financial Toxicity and Logistical Burdens Facing Families of Children With Wilms Tumor
- 4 August 2023
- Published by Elsevier in Journal of Surgical Research
- Vol. 291, 640-645
Using Crowdfunding Campaigns to Examine Financial Toxicity and Logistical Burdens Facing Families of Children With Wilms Tumor
- 8 March 2023
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 58 (6) , 1191-1194
Risk of Surgical Intervention in Children with Diagnoses of Cancer and Preoperative Malnutrition: A National Analysis
- 8 March 2023
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 58 (6) , 1191-1194
Risk of Surgical Intervention in Children with Diagnoses of Cancer and Preoperative Malnutrition: A National Analysis
- 23 January 2023
- Published by Springer Nature in Global Surgical Education - Journal of the Association for Surgical Education
- Vol. 2 (1) , 1-6
Residents as a valuable asset: the financial benefits of residency program expansion
- 23 January 2023
- Published by Springer Nature in Global Surgical Education - Journal of the Association for Surgical Education
- Vol. 2 (1) , 1-6
Residents as a valuable asset: the financial benefits of residency program expansion
- 3 November 2022
- Published by Wiley in World Journal of Surgery
- Vol. 47 (2) , 545-551
Low Cost Gastroschisis Silo for Sub‐Saharan Africa: Testing in a Porcine Model
Background: Gastroschisis mortality in sub‐Saharan Africa (SSA) remains high at 59–100%. Silo inaccessibility contributes to this disparity. Standard of care (SOC) silos cost $240, while median monthly incomes in SSA are < $200. Our multidisciplinary American and Ugandan team designed and bench‐tested a low‐cost (LC) silo that costs < $2 and is constructed from locally available materials. Here we describe in vivo LC silo testing.Methods: A piglet gastroschisis model was achieved by eviscerating intestines through a midline incision. Eight piglets were randomized to LC or SOC silos. Bowel was placed into the LC or SOC silo, maintained for 1‐h, and reduced. Procedure times for placement, intestinal reduction, and silo removal were recorded. Tissue injury of the abdominal wall and intestine was assessed. Bacterial and fungal growth on silos was also compared.Results: There were no gross injuries to abdominal wall or intestine in either group or difference in minor bleeding. Times for silo application, bowel reduction, and silo removal between groups were not statistically or clinically different, indicating similar ease of use. Microbiologic analysis revealed growth on all samples, but density was below the standard peritoneal inoculum of 105 CFU/g for both silos. There was no significant difference in bacterial or fungal growth between LC and SOC silos.Conclusion: LC silos designed for manufacturing and clinical use in SSA demonstrated similar ease of use, absence of tissue injury, and acceptable microbiology profile, similar to SOC silos. The findings will allow our team to proceed with a pilot study in Uganda.
- 3 November 2022
- Published by Wiley in World Journal of Surgery
- Vol. 47 (2) , 545-551
Low Cost Gastroschisis Silo for Sub‐Saharan Africa: Testing in a Porcine Model
Background: Gastroschisis mortality in sub‐Saharan Africa (SSA) remains high at 59–100%. Silo inaccessibility contributes to this disparity. Standard of care (SOC) silos cost $240, while median monthly incomes in SSA are < $200. Our multidisciplinary American and Ugandan team designed and bench‐tested a low‐cost (LC) silo that costs < $2 and is constructed from locally available materials. Here we describe in vivo LC silo testing.Methods: A piglet gastroschisis model was achieved by eviscerating intestines through a midline incision. Eight piglets were randomized to LC or SOC silos. Bowel was placed into the LC or SOC silo, maintained for 1‐h, and reduced. Procedure times for placement, intestinal reduction, and silo removal were recorded. Tissue injury of the abdominal wall and intestine was assessed. Bacterial and fungal growth on silos was also compared.Results: There were no gross injuries to abdominal wall or intestine in either group or difference in minor bleeding. Times for silo application, bowel reduction, and silo removal between groups were not statistically or clinically different, indicating similar ease of use. Microbiologic analysis revealed growth on all samples, but density was below the standard peritoneal inoculum of 105 CFU/g for both silos. There was no significant difference in bacterial or fungal growth between LC and SOC silos.Conclusion: LC silos designed for manufacturing and clinical use in SSA demonstrated similar ease of use, absence of tissue injury, and acceptable microbiology profile, similar to SOC silos. The findings will allow our team to proceed with a pilot study in Uganda.
- 10 May 2021
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 38 (8) , 731-744
Non-inferiority of fragmented care for high-risk pediatric neuroblastoma patients: a single institution analysis
Pediatric neuroblastoma (NB) patients receive multi-modal therapy and may experience care fragmented among multiple institutions with a significant travel burden, which has been associated with poor outcomes for some adult cancers. We hypothesized that fragmented care for pediatric NB patients is associated with inferior outcomes compared to treatment consolidated at one location. We reviewed paper and electronic records for pediatric NB patients who received ≥1 hematopoietic stem cell transplant (HSCT) at Duke from 1990-2017. Fragmented care was defined by treatment at >1 institution and grouped by 2 institutions vs. 3+ institutions. Distances were calculated using Google Maps. To compare all care groups, we used Fisher’s Exact and Kruskal-Wallis tests for demographic and treatment characteristics, Kaplan-Meier for unadjusted overall survival (OS), and Cox proportional hazards for factors associated with OS. Of 127 eligible patients, 102 (80.3%) patients experienced fragmented care, with 17 treated at 3+ facilities. Kaplan-Meier analysis did not associate fragmented care with increased mortality (log-rank p = 0.13). With multivariate analysis, only earlier diagnostic decade and greater distance to HSCT remained significantly associated with worsened OS. In this single institutional study, we found fragmented care did not impact overall survival. Worsened overall survival was associated with increased travel distance for HSCT and further research should aim to improve supportive processes for patients undergoing HSCT for high-risk neuroblastoma.
- 10 May 2021
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 38 (8) , 731-744
Non-inferiority of fragmented care for high-risk pediatric neuroblastoma patients: a single institution analysis
Pediatric neuroblastoma (NB) patients receive multi-modal therapy and may experience care fragmented among multiple institutions with a significant travel burden, which has been associated with poor outcomes for some adult cancers. We hypothesized that fragmented care for pediatric NB patients is associated with inferior outcomes compared to treatment consolidated at one location. We reviewed paper and electronic records for pediatric NB patients who received ≥1 hematopoietic stem cell transplant (HSCT) at Duke from 1990-2017. Fragmented care was defined by treatment at >1 institution and grouped by 2 institutions vs. 3+ institutions. Distances were calculated using Google Maps. To compare all care groups, we used Fisher’s Exact and Kruskal-Wallis tests for demographic and treatment characteristics, Kaplan-Meier for unadjusted overall survival (OS), and Cox proportional hazards for factors associated with OS. Of 127 eligible patients, 102 (80.3%) patients experienced fragmented care, with 17 treated at 3+ facilities. Kaplan-Meier analysis did not associate fragmented care with increased mortality (log-rank p = 0.13). With multivariate analysis, only earlier diagnostic decade and greater distance to HSCT remained significantly associated with worsened OS. In this single institutional study, we found fragmented care did not impact overall survival. Worsened overall survival was associated with increased travel distance for HSCT and further research should aim to improve supportive processes for patients undergoing HSCT for high-risk neuroblastoma.